In 2014, MPEG LA entered into a collaboration to develop and license therapeutic oligonucleotide conjugate technology. This led to Increscent Therapeutics™ – a versatile platform for ligand-directed multiple payload delivery of therapeutic oligonucleotides. For information on the technology and partnering/licensing opportunities:
For further information on licensing and collaborations, please contact our Biotech Group.
- CSHL Meeting, RNA & Oligonucleotide Therapeutics, Cold Spring Harbor Laboratories, New York (March 27-30, 2019)
- TIDES: Oligonucleotide and Peptide Therapeutics, San Diego, CA (May 21-23, 2019)
- BIO International, Philadelphia, PA (June 3-6, 2019)
- RNA Therapeutics: From Mechanism to Therapy, UMass Medical School, Worcester, MA (June 26-28, 2019)
- OTS Annual Meeting, Munich, Germany (October 13-16, 2019)